Ligne de temps

Agathe Aberlenc
Ingénieur(e) de Recherche
01 mars 2024
publication
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Lire plus08 juin 2022
publication
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.
Lire plus16 juil. 2021
publication
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
Lire plus05 févr. 2021
publication
Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
Lire plus09 oct. 2020
publication
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.
Lire plus25 sept. 2019
publication
CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).
Lire plus01 janv. 2019
publication
Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.
Lire plus11 mai 2015